A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
PURETECH HEALTH PLC ORD 1P operates in the Biotechnology industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | 8.3M |
| Net Income | 54M | 54M | -66M | -50M | -63M | 4.6M |
| EPS | $0.21 | $0.21 | $-0.24 | $-0.18 | $-0.21 | $0.02 |
| Free Cash Flow | 134M | 134M | -106M | -181M | -164M | 127M |
| ROIC | -109.7% | -27.4% | -24.0% | -45.1% | -36.9% | -21.0% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.37 | 0.40 | 0.11 | 0.23 | 0.24 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -136M | -136M | -146M | -198M | -150M | -120M |
| Operating Margin | 0.0% | - | - | - | - | -1433.1% |
| ROE | 12.9% | 12.2% | -13.0% | -8.9% | -10.1% | 0.7% |
| Shares Outstanding | 255M | 255M | 274M | 280M | 299M | 228M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | N/A | 8.3M | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | -86M | -82M | -110M | -152M | -96M | -69M | -69M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -135M | -120M | -150M | -198M | -146M | -136M | -136M |
| Op. Margin | N/A | -1433.1% | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | 366M | 4.6M | -63M | -50M | -66M | 54M | 54M |
| Net Margin | N/A | 54.8% | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | -21.2% | -21.0% | -36.9% | -45.1% | -24.0% | -27.4% | -109.7% |
| ROE | 56.3% | 0.7% | -10.1% | -8.9% | -13.0% | 12.2% | 12.9% |
| ROA | N/A | 0.5% | -6.5% | -6.1% | -9.4% | 8.3% | 8.9% |
| Cash Flow | |||||||
| Op. Cash Flow | -98M | 132M | -158M | -179M | -106M | 134M | 134M |
| Free Cash Flow | -110M | 127M | -164M | -181M | -106M | 134M | 134M |
| Owner Earnings | -119M | 114M | -180M | -202M | -115M | 108M | 108M |
| CapEx | 12M | 5.2M | 5.6M | 2.2M | 70K | 11K | 11K |
| Maint. CapEx | 6.7M | 6.6M | 7.3M | 8.9M | 4.9M | 3.6M | 3.6M |
| Growth CapEx | 5.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 6.7M | 6.6M | 7.3M | 8.9M | 4.9M | 3.6M | 3.6M |
| CapEx/OCF | N/A | 3.9% | N/A | N/A | N/A | 0.0% | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 26M | 20M | 4.8M | 4.8M |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 3.6% | 3.9% | 1.2% | 1.4% |
| Stock-Based Comp | 14M | 11M | 14M | 15M | 4.4M | 23M | 23M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||
| Net Debt | N/A | -248M | -330M | -92M | -6.7M | -127M | -281M |
| Cash & Equiv. | 132M | 404M | 466M | 150M | 191M | 281M | 281M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | 0.24 | 0.23 | 0.11 | 0.40 | 0.37 | 0.00 |
| Interest Coverage | -52.6 | -40.6 | -31.5 | -50.2 | -42.7 | -78.6 | -78.6 |
| Equity | 650M | 654M | 584M | 548M | 464M | 415M | 415M |
| Total Assets | N/A | 990M | 946M | 703M | 694M | 603M | 603M |
| Total Liabilities | N/A | 336M | 362M | 155M | 236M | 195M | 195M |
| Intangibles | N/A | N/A | N/A | N/A | 906K | 601K | 601K |
| Retained Earnings | N/A | 260M | 200M | 150M | 84M | 32M | 32M |
| Working Capital | N/A | 233M | 276M | 289M | 296M | 345M | 345M |
| Current Assets | N/A | 414M | 502M | 386M | 347M | 386M | 386M |
| Current Liabilities | N/A | 181M | 226M | 97M | 51M | 41M | 41M |
| Per Share Data | |||||||
| EPS | 1.44 | 0.02 | -0.21 | -0.18 | -0.24 | 0.21 | 0.21 |
| Owner EPS | -0.49 | 0.50 | -0.60 | -0.72 | -0.42 | 0.42 | 0.42 |
| Book Value | 2.65 | 2.86 | 1.96 | 1.96 | 1.70 | 1.63 | 1.63 |
| Cash Flow/Share | -0.40 | -0.58 | -0.53 | -0.64 | -0.39 | -0.53 | 0.22 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 245.7M | 228.4M | 298.6M | 279.7M | 273.7M | 254.8M | 254.8M |
| Valuation | |||||||
| P/E Ratio | 2.1 | 186.5 | -13.8 | -14.7 | -7.6 | 7.4 | 6.2 |
| P/FCF | N/A | 6.7 | N/A | N/A | N/A | 2.9 | 2.5 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 1.1 | 1.3 | 1.5 | 1.4 | 1.1 | 0.9 | 0.8 |
| Price/Sales | N/A | 102.1 | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | -14.8% | 14.9% | -19.0% | -24.4% | -21.2% | 34.1% | 40.5% |
| Market Cap | 747M | 852M | 864M | 741M | 499M | 394M | 332M |
| Avg. Price | 2.25 | 2.74 | 3.62 | 2.23 | 2.09 | 1.85 | 1.30 |
| Year-End Price | 3.04 | 3.73 | 2.90 | 2.65 | 1.82 | 1.55 | 1.30 |
PURETECH HEALTH PLC ORD 1P passes 0 of 9 quality checks, indicating weak fundamentals.
PURETECH HEALTH PLC ORD 1P trades at 6.2x trailing earnings, compared to its 15-year median P/E of 4.7x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 2.5x vs a median of 4.8x. Total shareholder yield (buybacks) is 1.4%. At current prices, the estimated annualized return to fair value is +10.3%.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a current P/E ratio of 6.2, compared to its historical median P/E of 4.7. The stock is currently considered Fair based on its historical valuation range.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a 5-year average return on invested capital (ROIC) of -30.9%. This is below average and may indicate limited pricing power.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a market capitalization of $332M. It is classified as a small-cap stock.
PURETECH HEALTH PLC ORD 1P (PRTC-L) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.44%.
Based on historical P/E analysis, PURETECH HEALTH PLC ORD 1P (PRTC-L) appears fair. The current P/E of 6.2 is 31% above its historical median of 4.7. The estimated fair value CAGR (P/E method) is -28.7%.
PURETECH HEALTH PLC ORD 1P (PRTC-L) operates in the Biotechnology industry, within the Healthcare sector.
PURETECH HEALTH PLC ORD 1P (PRTC-L) generated $134 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a debt-to-equity ratio of 0.37. This indicates a conservatively financed balance sheet.
PURETECH HEALTH PLC ORD 1P (PRTC-L) reported earnings per share (EPS) of $0.21 in its most recent fiscal year.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a return on equity (ROE) of 12.2%. This indicates moderate shareholder returns.
The Ledger Terminal provides 6 years of financial data for PURETECH HEALTH PLC ORD 1P (PRTC-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
PURETECH HEALTH PLC ORD 1P (PRTC-L) has a book value per share of $1.63, based on its most recent annual SEC filing.
No recent press releases.